falsefalse

Evolving Treatment Strategies in High-Risk Neuroblastoma - Episode 2

Approaches to Diagnosing Neuroblastoma

,

Anurag Agrawal, MD, explains his approaches to diagnosing neuroblastoma, including urine markers, imaging, and bone marrow sampling, and emphasizes age and disease dissemination as major prognostic indicators alongside genetic predisposition and treatment response.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: An Overview of Neuroblastoma
    Now Viewing
    EP. 2: Approaches to Diagnosing Neuroblastoma
    EP. 3: Role of CURIE Scores in the Treatment and Management of Neuroblastoma
    EP. 4: Current Treatment Paradigm for Newly Diagnosed Neuroblastoma
    EP. 5: Differentiating Refractory and Relapsed Neuroblastoma
    EP. 6: Updated Data From the LEAHRN Study in High-Risk Neuroblastoma
    EP. 7: Available Treatment Options for Recurrent/Relapsed High-Risk Neuroblastoma (R/R HRNB)
    EP. 8: Anti-GD2 Monoclonal Antibodies in Patients With R/R HRNB: Pivotal Clinical Trials
    EP. 9: Strategies for Adverse Effect Management and Treatment Optimization With Anti-GD2 Monoclonal Antibodies in R/R
    EP. 10: Future Perspectives in the Treatment of Neuroblastoma

    Related Content:

    Evolving Treatment Strategies in High-Risk NeuroblastomaOncLive News Network®
    Treatment Trends and Ongoing Research in Pediatric Acute Leukemia
    Factors to Consider in Pediatric Acute Leukemia Management
    Breaking Down Treatment Expectations With Revumenib in Pediatric KMT2A+ R/R Acute Leukemia
    x